Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Dec 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Odyssey buys BenevolentAI in Europe's top SPAC deal

Feb 18
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investors love data. So why not dig into sustainability metrics?

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence In Drug Discovery

Oct 17
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Source Code of Life

Jan 4
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst reports trendsetting biotech breakthroughs

Sep 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Harnessing artificial intelligence to help prevent epidemics before they spread

Jul 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI and the Global Economic Pivot to Sustainability

Sep 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Drug discovery platform Exscientia sets terms for $275 million US IPO

Mar 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

These are the biggest trends in clean tech in 2021

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement